CWM, LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
CWM, LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17
+183.3%
1,500
+400.0%
0.00%
Q2 2023$6
+20.0%
300
+147.9%
0.00%
Q1 2023$5
-28.6%
121
-13.6%
0.00%
Q4 2022$7
-99.8%
140
+145.6%
0.00%
Q3 2022$3,0000.0%570.0%0.00%
Q2 2022$3,00057
+1800.0%
0.00%
Q1 2022$0
-100.0%
3
-57.1%
0.00%
Q4 2021$1,00070.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 936,777$53,218,00016.69%
Fairmount Funds Management LLC 316,952$18,006,0006.55%
ARMISTICE CAPITAL, LLC 1,836,000$104,303,0001.77%
Soleus Capital Management, L.P. 182,400$10,362,0001.62%
Portland Global Advisors LLC 62,635$3,558,0000.66%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 40,000$2,263,0000.55%
FARALLON CAPITAL MANAGEMENT LLC 1,995,000$113,336,0000.53%
Yorktown Management & Research Co Inc 10,400$591,0000.44%
Hennion & Walsh Asset Management, Inc. 120,240$6,831,0000.36%
Virtus ETF Advisers LLC 9,599$545,0000.24%
View complete list of ENANTA PHARMACEUTICALS INC shareholders